![Somatic Hypermutation and Framework Mutations of Variable Region Contribute to Anti-Zika Virus-Specific Monoclonal Antibody Binding and Function | Journal of Virology Somatic Hypermutation and Framework Mutations of Variable Region Contribute to Anti-Zika Virus-Specific Monoclonal Antibody Binding and Function | Journal of Virology](https://journals.asm.org/cms/10.1128/jvi.00071-22/asset/dd327ea1-dd92-43eb-ab3e-28e320659293/assets/images/large/jvi.00071-22-f005.jpg)
Somatic Hypermutation and Framework Mutations of Variable Region Contribute to Anti-Zika Virus-Specific Monoclonal Antibody Binding and Function | Journal of Virology
![Resolved: Low‐dose prednisone is indicated as a standard treatment in patients with rheumatoid arthritis - Conn - 2001 - Arthritis Care & Research - Wiley Online Library Resolved: Low‐dose prednisone is indicated as a standard treatment in patients with rheumatoid arthritis - Conn - 2001 - Arthritis Care & Research - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/5bffd3e3-3cdb-490f-a93c-669daba64c5b/acr.v74.8.cover.jpg?trick=1658984252355)
Resolved: Low‐dose prednisone is indicated as a standard treatment in patients with rheumatoid arthritis - Conn - 2001 - Arthritis Care & Research - Wiley Online Library
![Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis | PNAS Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis | PNAS](https://www.pnas.org/cms/10.1073/pnas.2116271119/asset/b6b6eca4-b9d3-4167-b200-01e9c5074afd/assets/images/large/pnas.2116271119fig04.jpg)
Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis | PNAS
Stainless steel "X" stool with loose upholstered cushion by Francois Monnet for Kappa France c. 1969 Dimensions: W: 1
1 ITEM #: 25__ DATE: 03-23-21 COUNCIL ACTION FORM SUBJECT: DEMOLITION OF GREEK HOUSE AT 120 LYNN AVENUE BACK
![Release and co-release of model hydrophobic and hydrophilic actives from 3D printed kappa-carrageenan emulsion gels - ScienceDirect Release and co-release of model hydrophobic and hydrophilic actives from 3D printed kappa-carrageenan emulsion gels - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0268005X22003721-ga1.jpg)
Release and co-release of model hydrophobic and hydrophilic actives from 3D printed kappa-carrageenan emulsion gels - ScienceDirect
![Biomedicines | Free Full-Text | Immunoglobulins or Antibodies: IMGT® Bridging Genes, Structures and Functions | HTML Biomedicines | Free Full-Text | Immunoglobulins or Antibodies: IMGT® Bridging Genes, Structures and Functions | HTML](https://www.mdpi.com/biomedicines/biomedicines-08-00319/article_deploy/html/images/biomedicines-08-00319-g001.png)
Biomedicines | Free Full-Text | Immunoglobulins or Antibodies: IMGT® Bridging Genes, Structures and Functions | HTML
![Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis | PNAS Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis | PNAS](https://www.pnas.org/cms/asset/375dc1fd-0481-453c-b97b-fa2cb6644d30/keyimage.jpg)
Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis | PNAS
![Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-021-88118-6/MediaObjects/41598_2021_88118_Fig4_HTML.png)
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports
![Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.7b00109/asset/images/large/jm-2017-00109c_0010.jpeg)
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
![Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-021-88118-6/MediaObjects/41598_2021_88118_Fig2_HTML.png)
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports
![Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis | PNAS Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis | PNAS](https://www.pnas.org/cms/10.1073/pnas.2116271119/asset/9c199891-c9ac-4f5d-8add-724907012622/assets/images/large/pnas.2116271119fig05.jpg)